Visit-to-visit blood pressure variability and progression of white matter hyperintensities over 14 years

References

• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):1–10. doi: 10.1016/S1474-4422(10)70104-6
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–696. doi: 10.1016/S1474-4422(19)30079-1
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838. doi: 10.1016/S1474-4422(13)70124-8.
   PubMed Web of Science ®Google Scholar
• Dallaire-Théroux C, Callahan BL, Potvin O, et al. Radiological-pathological correlation in Alzheimer’s disease: systematic review of antemortem magnetic resonance imaging findings. J Alzheimers Dis. 2017;57(2):575–601. doi: 10.3233/JAD-161028.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Benveniste H, Williams A. Cerebral vascular dysfunctions detected in human small vessel disease and implications for preclinical studies. Annu Rev Physiol. 2022;84(1):409–434. doi: 10.1146/annurev-physiol-060821-014521.
   PubMedGoogle Scholar
• Nasrallah IM ,Pajewski NM ,Auchus AP, et al. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA. 2019;322(6):524–534. doi:10.1001/jama.2019.10551.
   PubMed Web of Science ®Google Scholar
• van Middelaar T, van Vught LA, van Gool WA, et al. Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis. J Hypertens. 2018;36(9):1780–1787. doi: 10.1097/HJH.0000000000001829.
   PubMed Web of Science ®Google Scholar
• Benavente OR, Coffey CS, Conwit R, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382(9891):507–515.doi: 10.1016/S0140-6736(13)60852-1.
   PubMed Web of Science ®Google Scholar
• Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375(9718):938–948. doi: 10.1016/S0140-6736(10)60309-1
   PubMed Web of Science ®Google Scholar
• Hastie CE, Jeemon P, Coleman H, et al. Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14 522 patients with hypertension. Hypertension. 2013;62(4):698–705. doi: 10.1161/HYPERTENSIONAHA.113.01343.
   PubMed Web of Science ®Google Scholar
• de Heus RAA, Tzourio C, Lee EJL, et al. Association between blood pressure variability with dementia and cognitive impairment: a systematic review and meta-analysis. Hypertension. 2021;78(5):1478–1489. doi: 10.1161/HYPERTENSIONAHA.121.17797.
   PubMed Web of Science ®Google Scholar
• Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098. doi: 10.1136/bmj.i4098.
   PubMed Web of Science ®Google Scholar
• Ma Y, Song A, Viswanathan A, et al. Blood pressure variability and cerebral small vessel disease a systematic review and meta-analysis of population-based ­cohorts. Stroke. 2020;51(1):82–89. doi: 10.1161/STROKEAHA.119.026739.
   PubMed Web of Science ®Google Scholar
• Tully PJ, Yano Y, Launer LJ, et al. Association between blood pressure variability and cerebral small-vessel disease: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(1):e013841. doi: 10.1161/JAHA.119.013841.
   PubMed Web of Science ®Google Scholar
• van Middelaar T, Richard E, Moll van Charante EP, et al. Visit-to-visit blood pressure variability and progression of white matter hyperintensities among older people with hypertension. J Am Med Dir Assoc. 2019;20(9):1175–1177.e1. doi: 10.1016/j.jamda.2019.04.003.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yilmaz P, Bos D, et al. Blood pressure variation and subclinical brain disease. J Am Coll Cardiol. 2020;75(19):2387–2399. doi: 10.1016/j.jacc.2020.03.043.
   PubMed Web of Science ®Google Scholar
• van Norden AG, de Laat KF, Gons RA, et al. Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol. BMC Neurol. 2011;11(1):29. doi: 10.1186/1471-2377-11-29.
   PubMedGoogle Scholar
• Cai M, Jacob MA, van Loenen MR, et al. Determinants and temporal dynamics of cerebral small vessel disease: 14-Year follow-Up. Stroke. 2022;53(9):2789–2798. doi: 10.1161/STROKEAHA.121.038099.
   PubMed Web of Science ®Google Scholar
• Ghafoorian M, Karssemeijer N, van Uden IWM, et al. Automated detection of white matter hyperintensities of all sizes in cerebral small vessel disease. Med Phys. 2016;43(12):6246–6258. doi: 10.1118/1.4966029.
   PubMed Web of Science ®Google Scholar
• Long J, Shelhamer E, Darrell T. Fully convolutional networks for semantic segmentation. In Proceedings of the 2015 IEEE Conference on Computer Vision and Pattern Recognition (Cvpr); 2015. p. 3431–3440. doi: 10.1109/CVPR.2015.7298965.
   Google Scholar
• Duering M, Csanadi E, Gesierich B, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain. 2013;136(Pt 9):2717–2726. doi: 10.1093/brain/awt184.
   PubMedGoogle Scholar
• Baykara E, Gesierich B, Adam R, et al. A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms. Ann Neurol. 2016;80(4):581–592. doi: 10.1002/ana.24758.
   PubMed Web of Science ®Google Scholar
• Brown R, Low A, Markus HS. Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design. J Neurol Neurosurg Psychiatry. 2021;92(12):1271–1277. doi: 10.1136/jnnp-2021-326569.
   PubMed Web of Science ®Google Scholar
• Bilo G, Parati G. Blood pressure variability and kidney disease: another vicious circle? J Hypertens. 2018;36(5):1019–1021. doi: 10.1097/HJH.0000000000001707.
   PubMed Web of Science ®Google Scholar
• Gutteridge DS, Tully PJ, Ghezzi ES, et al. Blood pressure variability and structural brain changes: a systematic review. J Hypertens. 2022;40(6):1060–1070. doi: 10.1097/HJH.0000000000003133.
   PubMed Web of Science ®Google Scholar
• Blair GW, Hernandez MV, Thrippleton MJ, et al. Advanced neuroimaging of cerebral small vessel disease. Curr Treat Options Cardiovasc Med. 2017;19(7):56. doi: 10.1007/s11936-017-0555-1.
   PubMedGoogle Scholar
• Cyr AR, Huckaby LV, Shiva SS, et al. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36(2):307–321. doi: 10.1016/j.ccc.2019.12.009.
   PubMed Web of Science ®Google Scholar
• Eto M, Toba K, Akishita M, et al. Reduced endothelial vasomotor function and enhanced neointimal formation after vascular injury in a rat model of blood pressure lability. Hypertens Res. 2003;26(12):991–998. doi: 10.1291/hypres.26.991.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, van Buchem MA, Sigurdsson S, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene/environment Susceptibility - Reykjavik study. Brain. 2011;134(Pt 11):3398–3407. doi: 10.1093/brain/awr253.
   PubMedGoogle Scholar
• Ma Y, Blacker D, Viswanathan A, et al. Visit-to-visit blood pressure variability, neuropathology, and cognitive function. Neurology. 2021;96(23):e2812–e2823. doi: 10.1212/WNL.0000000000012065.
   PubMed Web of Science ®Google Scholar
• Zhou TL, Henry RMA, Stehouwer CDA, et al. Blood pressure variability, arterial stiffness, and arterial remodeling: the Maastricht study. Hypertension. 2018;72(4):1002–1010. doi: 10.1161/HYPERTENSIONAHA.118.11325.
   PubMed Web of Science ®Google Scholar
• de Havenon A, Anadani M, Prabhakaran S, et al. Increased blood pressure variability and the risk of probable dementia or mild cognitive impairment: a post hoc analysis of the SPRINT MIND trial. J Am Heart Assoc. 2021;10(18):e022206. doi: 10.1161/JAHA.121.022206.
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G. Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability: evidence from day-by-day home blood pressure monitoring. Hypertension. 2012;59(6):1091–1093. doi: 10.1161/HYPERTENSIONAHA.112.193037.
   PubMed Web of Science ®Google Scholar
• Parati G, Ochoa JE, Lombardi C, et al. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143–155. doi: 10.1038/nrcardio.2013.1.
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G, Kollias A, et al. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management-a European society of hypertension position paper*. J Hypertens. 2023;41(4):527–544. doi: 10.1097/HJH.0000000000003363.
   PubMed Web of Science ®Google Scholar
• Kloppenborg RP, Nederkoorn PJ, Geerlings MI, et al. Presence and progression of white matter hyperintensities and cognition A meta-analysis. Neurology. 2014;82(23):2127–2138. doi: 10.1212/WNL.0000000000000505.
   PubMed Web of Science ®Google Scholar
• Webb AJS, Fischer U, Mehta Z, et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906–915. doi: 10.1016/S0140-6736(10)60235-8
   PubMed Web of Science ®Google Scholar
• Maseli A, Aeschbacher S, Schoen T, et al. Healthy lifestyle and blood pressure variability in young adults. Am J Hypertens. 2017;30(7):690–699. doi: 10.1093/ajh/hpx034.
   PubMed Web of Science ®Google Scholar